clinical medicine
3,770 projects
oncology1,857cardiology336endocrinology314psychiatry250embryology236surgery212physiotherapy149obstetrics142pneumology137ophthalmology122transplantation119gastroenterology94angiology69rheumatology67allergology60hepatology59nephrology51radiology36hematology28critical care medicine19gynaecology19odontology16otorhinolaryngology15orthopaedics13
HEIndividual fellowship2026–2028Sweden
SPARC · Spatial profiling of gastric cancer with peritoneal carcinomatosis to tackle cancer spreading and improve precision immuno-oncology
2 partners · 2 countries
HEIndividual fellowship2026–2028Germany
MetaMOF · Balancing Act: Understanding metabolic regulation via the acetyltransferase MOF during Drosophila embryogenesis
HEIndividual fellowship2026–2028Spain
Path-B SHM · Pathology-based Structural Health Monitoring
2 partners · 2 countries
HEIndividual fellowship2026–2028France
ICONES · Ion-ion COllisioN Electron Spectroscopy
HEIndividual fellowship2026–2028Netherlands
T-REaCT · Evolution of T cell reactivity against somatic mutations across human colon cancer stages with single-cell genomics and synthetic T cell specificity screening
3 partners · 2 countries
HEIndividual fellowship2026–2028Spain
MechanoSecret · Exploring the Mechanobiology of the Secretory pathway across scales
HEIndividual fellowship2026–2028United Kingdom
syRNAlb · Human serum albumin nanoparticles for synergistic chemotherapy and oligonucleotide therapy against oncogenic lncRNAs in lung cancer
HEIndividual fellowship2026–2028Czechia
Nano-LYTAC · Nanotherapeutic platform for lysosomal targeted technology
2 partners
HEIndividual fellowship2026–2028Austria
MorphoPace · Understanding the conserved mechanisms pacing morphogenesis
HEIndividual fellowship2026–2028United Kingdom
NatK · Harnessing natural killer cells to combat chemotherapy resistance
HEIndividual fellowship2026–2028Cyprus
InSilicoCAPP · In silico modelling of cold atmospheric pressure plasma on cholangiocarcinoma
3 partners · 2 countries
HEIndividual fellowship2026–2029United Kingdom
AtheroCaSR · Direct implication of the Calcium Sensing Receptor in Vascular Calcifiction and Atherosclerosis in Chronic Kidney Disease
2 partners
HEIndividual fellowship2026–2027United Kingdom
MyCyclop · Mycolic Acid Cyclopropane Synthase Enzymes as New Biocatalysts for Green Cyclopropanation Reactions
HEIndividual fellowship2026–2029Denmark
LINK2CNS · Unique and overlapping functions and CNS sites of action for NK2R and LepR signaling
2 partners · 2 countries
HEIndividual fellowship2026–2028Spain
DiscoverableTumor · Oncogene-driven immunosuppression via glyco-immune checkpoint modulation in pancreatic ductal adenocarcinoma.
HEIndividual fellowship2026–2028United Kingdom
B-REDiTx · Optimising cancer therapy scheduling through personalised mechanistic models and reinforcement learning
HEIndividual fellowship2026–2028Luxembourg
LINK-M · Investigating the Interplay of Natural Killer Cells and Microbiome in Non-Hodgkin's Lymphoma
HEIndividual fellowship2026–2028France
DCsConCargo · Investigating DC migration with large, ingested cargos through confining environments
HEIndividual fellowship2026–2028Germany
HERSTRUCT · Decoding the Structural and Functional Dynamics of HER2-HER3 in Cancer through Advanced Cryo-Electron Tomography
HEIndividual fellowship2026–2028Germany
COSINE · COmpton Scatter based Imaging for Nuclear Emissions
HEIndividual fellowship2026–2028France
KNEEUL · Approach for Unloading Knee Joint Cartilage Pressure: Potential Applications in Post-Surgical Rehabilitation
HEIndividual fellowship2026–2028Belgium
4GETasthma · Evicting pathogenic type-2 resident memory T cells from the lungs of asthmatics
HEIndividual fellowship2026–2028Belgium
CALM-GBM · Circuit control by Astrocytes Located in Microenvironment of Glioblastoma
HEIndividual fellowship2026–2028Sweden